Detection of vascular endothelial growth factor (VEGF) and VEGF receptors Flt-1 and KDR in canine mastocytoma cells

Veterinary Immunology and Immunopathology

Volumn 115, Issue 3-4, 2007, Pages 320-333

  Rebuzzi, Laura ^a,b   Willmann, Michael ^a   Sonneck, Karoline ^b   Gleixner, Karoline V ^b   Florian, Stefan ^b   Kondo, Rudin ^b   Mayerhofer, Matthias ^b   Vales, Anja ^b   Gruze, Alexander ^c   Pickl, Winfried F ^c   Thalhammer, Johann G ^a   Valent, Peter ^b  

^a UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Angiogenesis; Flt 1; KDR; Mastocytoma; VEGF

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; BEVACIZUMAB; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; RAPAMYCIN; RECOMBINANT VASCULOTROPIN; THYMIDINE; TRITIUM; VASCULOTROPIN; VASCULOTROPIN ANTIBODY; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOG; DOWN REGULATION; FEMALE; GROWTH REGULATION; IMMUNOHISTOCHEMISTRY; MALE; MAST CELL; MASTOCYTOMA; NONHUMAN; NORTHERN BLOTTING; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE SECTION; TUMOR GROWTH; UPREGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ANTIBODIES, MONOCLONAL; BLOTTING, NORTHERN; CELL LINE, TUMOR; CHROMONES; DOG DISEASES; DOGS; FEMALE; FLAVONOIDS; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; MALE; MASTOCYTOMA; MORPHOLINES; PROTEIN KINASE INHIBITORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SIROLIMUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 33846184758     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2006.11.009     Document Type: Article

References (45)

1. Agis H., Krauth M.T., Bohm A., Mosberger I., Mullauer L., Simonitsch-Klupp I., Walls A.F., Horny H.P., and Valent P. Identification of basogranulin (BB1) as a novel immunohistochemical marker of basophils in normal bone marrow and patients with myeloproliferative disorders. Am. J. Clin. Pathol. 125 (2006) 273-281
2. Artuc M., Hermes B., Steckelings U.M., Grutzkau A., and Henz B.M. Mast cells and their mediators in cutaneous wound healing-active participants or innocent bystanders?. Exp. Dermatol. 8 (1999) 1-16
3. Boesiger J., Tsai M., Maurer M., Yamaguchi M., Brown L.F., Claffey K.P., Dvorak H.F., and Galli S.J. Mast cells can secrete vascular permeability factor/vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of fc epsilon receptor I expression. J. Exp. Med. 188 (1998) 1135-1145
4. Bostock D.E. The prognosis following surgical removal of mastocytomas in dogs. J. Small. Anim. Pract. 14 (1973) 27-41
5. Cahalane A.K., Payne S., Barber L.G., Duda L.E., Henry C.J., Mauldin G.E., Frimberger A.E., Cotter S.M., and Moore A.S. Prognostic factors for survival of dogs with inguinal and perineal mast cell tumors treated surgically with or without adjunctive treatment: 68 cases (1994-2002). J. Am. Vet. Med. Assoc. 225 (2004) 401-408
6. Cattoretti G., Pileri S., Parravicini C., Becker M.H., Poggi S., Bifulco C., Key G., D'Amato L., Sabattini E., Feudale E., et al. Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections. J. Pathol. 171 (1993) 83-98
7. Chomczynski P. One-hour downward alkaline capillary transfer for blotting of DNA and RNA. Anal. Biochem. 201 (1992) 134-139
8. DeVinney R., and Gold W.M. Establishment of two dog mastocytoma cell lines in continuous culture. Am. J. Respir. Cell. Mol. Biol. 3 (1990) 413-420
9. Escribano L., Orfao A., Diaz-Agustin B., Villarrubia J., Cervero C., Lopez A., Marcos M.A., Bellas C., Fernandez-Canadas S., Cuevas M., Sanchez A., Velasco J.L., Navarro J.L., and Miguel J.F. Indolent systemic mast cell disease in adults: immunophenotypic characterization of bone marrow mast cells and its diagnostic implications. Blood 91 (1998) 2731-2736
10. Escribano L., Diaz-Agustin B., Bellas C., Navalon R., Nunez R., Sperr W.R., Schernthaner G.H., Valent P., and Orfao A. Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis. Leuk. Res. 25 (2001) 563-570
11. Ferrara N., Gerber H.P., and LeCouter J. The biology of VEGF and its receptors. Nat. Med. 9 (2003) 669-676
12. Gabillot-Carre M., Lepelletier Y., Humbert M., de Sepuvelda P., Ben Hamouda N., Zappulla J.P., Liblau R., Ribadeau-Dumas A., Machavoine F., Letard S., Baude C., Hermant A., Yang Y., Vargaftig J., Bodemer C., Morelon E., Lortholary O., Recher C., Laurent G., Dy M., Arock M., Dubreuil P., and Hermine O. Rapamycin inhibits growth and survival of D-816-V-mutated c-kit mast cells. Blood 108 (2006) 1065-1072
13. Gerber H.P., and Ferrara N. The role of VEGF in normal and neoplastic hematopoiesis. J. Mol. Med. 81 (2003) 20-31
14. Giles F.J. The vascular endothelial growth factor (VEGF) signaling pathway: a therapeutic target in patients with hematologic malignancies. Oncologist 5 (2001) 32-39
15. Govier S.M. Principles of treatment for mast cell tumors. Clin. Tech. Small. Anim. Pract. 18 (2003) 103-106
16. Hsu S.M., Raine L., and Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 29 (1981) 577-580
17. Jones C.L., Grahn R.A., Chien M.B., Lyons L.A., and London C.A. Detection of c-kit mutations in canine mast cell tumors using fluorescent polyacrylamide gel electrophoresis. J. Vet. Diagn. Invest. 16 (2004) 95-100
18. Krauth M.T., Majlesi Y., Florian S., Bohm A., Hauswirth A.W., Ghannadan M., Wimazal F., Raderer M., Wrba F., and Valent P. Cell surface membrane antigen phenotype of human gastrointestinal mast cells. Int. Arch. Allergy. Immunol. 138 (2005) 111-120
19. London C.A., and Seguin B. Mast cell tumors in the dog. Vet. Clin. N. Am. Small. Anim. Pract. 33 (2003) 473-489
20. London C.A., Galli S.J., Yuuki T., Hu Z.Q., Helfand S.C., and Geissler E.N. Spontaneous canine mast cell tumors express tandem duplications in the proto-oncogene c-kit. Exp. Hematol. 27 (1999) 689-697
21. Macy D.W. Canine mast cell tumors. Vet. Clin. N. Am. Small. Anim. Pract. 15 (1985) 783-803
22. Mayerhofer M., Valent P., Sperr W.R., Griffin J.D., and Sillaber C. BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1alpha, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin. Blood 100 (2002) 3767-3775
23. Mayerhofer M., Florian S., Krauth M.T., Aichberger K.J., Bilban M., Marculescu R., Printz D., Fritsch G., Wagner O., Selzer E., Sperr W.R., Valent P., and Sillaber C. Identification of heme oxygenase-1 as a novel BCR/ABL-dependent survival factor in chronic myeloid leukemia. Cancer Res. 64 (2004) 3148-3154
24. Mayerhofer M., Aichberger K.J., Florian S., Krauth M.T., Hauswirth A.W., Derdak S., Sperr W.R., Esterbauer H., Wagner O., Marosi C., Pickl W.F., Deininger M., Weisberg E., Druker B.J., Griffin J.D., Sillaber C., and Valent P. Identification of mTOR as a novel bifunctional target in chronic myeloid leukemia: dissection of growth-inhibitory and VEGF-suppressive effects of rapamycin in leukemic cells. FASEB J. 19 (2005) 960-962
25. Millanta F., Silvestri G., Vaselli C., Citi S., Pisani G., Lorenzi D., and Poli A. The role of vascular endothelial growth factor and its receptor Flk-1/KDR in promoting tumour angiogenesis in feline and canine mammary carcinomas: a preliminary study of autocrine and paracrine loops. Res. Vet. Sci. 81 (2006) 350-357
26. Misdorp W. Mast cells and canine mast cell tumours: a review. Vet. Q. 26 (2004) 156-169
27. Neufeld G., Cohen T., Gengrinovitch S., and Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 13 (1999) 9-22
28. Patnaik A.K., Ehler W.J., and MacEwen E.G. Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs. Vet. Pathol. 21 (1984) 469-474
29. Ranieri G., Passantino L., Patruno R., Passantino G., Jirillo F., Catino A., Mattioli V., Gadaleta C., and Ribatti D. The dog mast cell tumour as a model to study the relationship between angiogenesis, mast cell density and tumour malignancy. Oncol. Rep. 10 (2003) 1189-1193
30. Reguera M.J., Rabanal R.M., Puigdemont A., and Ferrer L. Canine mast cell tumors express stem cell factor receptor. Am. J. Dermatopathol. 22 (2000) 49-54
31. Restucci B., Papparella S., Maiolino P., and De Vico G. Expression of vascular endothelial growth factor in canine mammary tumors. Vet. Pathol. 39 (2002) 488-493
32. Restucci B., Borzacchiello G., Maiolino P., Martano M., Paciello O., and Papparella S. Expression of vascular endothelial growth factor receptor Flk-1 in canine mammary tumours. J. Comp. Pathol. 130 (2004) 99-104
33. Riva F., Brizzola S., Stefanello D., Crema S., and Turin L. A study of mutations in the c-kit gene of 32 dogs with mastocytoma. J. Vet. Diagn. Invest. 17 (2005) 385-388
34. Rogers K.S. Mast cell tumors: dilemmas of diagnosis and treatment. Vet. Clin. N. Am. Small. Anim. Pract. 26 (1996) 87-102
35. Shinkaruk S., Bayle M., Lain G., and Deleris G. Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy. Curr. Med. Chem. Anti-Cancer Agents 3 (2003) 95-117
36. Siemeister G., Martiny-Baron G., and Marme D. The pivotal role of VEGF in tumor angiogenesis: molecular facts and therapeutic opportunities. Cancer Metastasis Rev. 17 (1998) 241-248
37. Szukiewicz D., Gujski M., Maslinska D., Szewczyk G., Bachanek M., and Maslinski S. Mast cell-derived VEGF and VEGF receptor type 1, 2, and 3 expression in human term trophoblast culture-influence of hypoxia. Inflamm. Res. S1 (2005) 82-83
38. Valent P., Ashman L.K., Hinterberger W., Eckersberger F., Majdic O., Lechner K., and Bettelheim P. Mast cell typing: demonstration of a distinct hematopoietic cell type and evidence for immunophenotypic relationship to mononuclear phagocytes. Blood 73 (1989) 1778-1785
39. Valent P., and Bettelheim P. Cell surface structures on human basophils and mast cells: biochemical and functional characterization. Adv. Immunol. 52 (1992) 333-423
40. Valent P., Schernthaner G.H., Sperr W.R., Fritsch G., Agis H., Willheim M., Buhring H.J., Orfao A., and Escribano L. Variable expression of activation-linked surface antigens on human mast cells in health and disease. Immunol. Rev. 179 (2001) 74-81
41. Veikkola T., Karkkainen M., Claesson-Welsh L., and Alitalo K. Regulation of angiogenesis via vascular endothelial growth factor receptors. Cancer Res. 60 (2000) 203-212
42. Weidner N., Semple J.P., Welch W.R., and Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N. Engl. J. Med. 324 (1991) 1-8
43. Wergin M.C., and Kaser-Hotz B. Plasma vascular endothelial growth factor (VEGF) measured in seventy dogs with spontaneously occurring tumours. In Vivo 18 (2004) 15-19
44. Wergin M.C., Ballmer-Hofer K., Roos M., Achermann R.E., Inteeworn N., Akens M.K., Blattmann H., and Kaser-Hotz B. Preliminary study of plasma vascular endothelial growth factor (VEGF) during low- and high-dose radiation therapy of dogs with spontaneous tumors. Vet. Radiol. Ultrasound 45 (2004) 247-254
45. Wimazal F., Jordan J.H., Sperr W.R., Chott A., Dabbass S., Lechner K., Horny H.P., and Valent P. Increased angiogenesis in the bone marrow of patients with systemic mastocytosis. Am. J. Pathol. 160 (2002) 1639-1645